symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
NVRO,16.96,0.840304,478659,612596896,0,15.905-48.1,-0.02,Nevro Corp.,USD,0001444380,US64157F1030,64157F103,New York Stock Exchange,NYSE,Medical Devices,https://www.nevro.com,"Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.",Mr. Kevin R. Thornal,Healthcare,US,1087,650 251 0005,1800 Bridge Parkway,Redwood City,CA,94065,7.32517,44.0052,https://financialmodelingprep.com/image-stock/NVRO.png,2014-11-06,False,False,True,False,False
